Market research
ESE.AU eSense-Lab Ltd
AU AUD Healthcare
Latest close
Latest stored close unavailable
Test a moving-average rule with historical data.
Market facts
- Market cap
- 9M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.46
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- AU000000ESE9
- Market cap
- 9M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 1.46
About
About eSense-Lab Ltd
eSense-Lab Ltd, a life sciences research and development company, specializes in the commercialization of phytochemical profiling of plants. It focuses on the development and manufacturing of terpene profiles of the cannabis plant for use in various applications, such as concentrates, medicine, topical treatments, e-liquids, beverages, personalized medicine, cosmetics, and food additives. The company was incorporated in 2016 and is based in Nes Tziona, Israel.
Research context
eSense-Lab Ltd appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ESE.AU discussion.
5 years, 6 months ago
eSense-Lab Ltd is currently in a long term uptrend where the price is trading 0.0% above its 200 day moving average.
From a valuation standpoint, the stock is 10.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 229.6.
eSense-Lab Ltd's total revenue sank by 87.5% to $1K since the same quarter in the previous year.
Its net income has dropped by 69.4% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 7.4% to $-376K since the same quarter in the previous year.
Based on the above factors, eSense-Lab Ltd gets an overall score of 3/5.